Digital health has been slowly making inroads into cardiovascular practice for several years. However, thanks to the COVID-19 pandemic and the sudden need for distance care, the digital transformation saw rapid acceleration, forcing practitioners, patients, and healthcare systems to adapt to this new digital reality.

For many surgeons, questions about fertility and family planning loom large as they grapple with when to start a family while working long hours in intense jobs. In this episode, find out more about fertility facts and myths, costs, and tips for making treatments more affordable, the pros and cons of genetic screening, and more.

A panel of Latina vascular and endovascular surgeons from across Latin America to highlight their unique perspectives on career and personal success hosted by vascular surgeons Dr. Alan Lumsden, President of the International Society of Endovascular Specialists, and Dr. Palma Shaw, ISEVS Secretary.

Today we’re exploring how institutions and leaders can tap into that idea of “why” to shape hospital culture to focus on the common good for patients and employees alike. Dr. Conrad Vial is a cardiac surgeon and the chief physician executive of operations for Sutter Health Bay Area, and he has dedicated his leadership career to putting “why” at the center of things.

In this episode, two of the nation’s leading researchers in cardiac regenerative medicine give us a primer in the principles of stem cell research for cardiovascular regeneration, and how these remarkable cells are being used to unlock potentially life-saving therapies for patients.

Beyond this year’s crisis, telemedicine has the potential to be a key tool in addressing larger socioeconomic and racial health disparities. a group of experts to discuss how institutions and physicians could use telemedicine to close the gaps in chronic diseases and mortality among underserved populations.

a group of cardiologists from around the United States to discuss barriers and solutions to quickly implementing telehealth in their institutions and the future of telemedicine beyond COVID-19.

In today’s podcast, we brought together a vascular surgeon, a cardiac surgeon, and one who does both to discuss training the cardiovascular surgeons of the future. The future classes of residents and fellows will need to learn more in less time, with a variety of tracks to choose from as the profession balances the needs for specialists and generalists and adjusts to technological changes.

Although there have been significant advances in reducing the overall burden of cardiovascular disease in the global population, there’s one group with decidedly less progress: young adults. In today's episode, Dr. Khurram Nasir leads a panel discussion exploring the emerging epidemics of acute MI and stroke in patients in their twenties, thirties, and forties, looking at underlying risk factors and tips for risk assessment, screenings, guidelines, and more.

As the COVID-19 pandemic has swept around the world, it has become apparent that the novel coronavirus causes much more than a respiratory disease. A substantial number of patients with COVID-19 have experienced cardiovascular complications ranging from an acute coronary syndrome to deep vein thrombosis, to microvascular injury. On today’s podcast, we’re bringing you a panel of cardiovascular experts to delve into how COVID-19 causes cardiovascular disease.

In recent years, minimally invasive cardiac surgery, or MICS, has revolutionized the cardiac surgery field, offering opportunities to minimize patient trauma and speed up recovery times for a variety of cardiac interventions. We gathered a group of MICS experts to give us a primer on MICS for cardiovascular healthcare professionals. They’ll go into what qualifies as minimally invasive cardiac surgery, how MICS has evolved over time, differences from traditional cardiac surgery, training considerations, the role of professional societies, and more.

Although COVID-19 is primarily an upper respiratory infection, there is increasing evidence of cardiovascular complications, and cardiac patients are particularly susceptible to severe infection. On today’s podcast, Dr. Mouaz Al-Mallah, cardiologist from Houston Methodist Hospital, delves into the cardiovascular considerations for COVID-19 infections and best practices for managing these complex patients.

This week, we’re sharing part two of our series on critical care for COVID-19 patients. Our critical care panel covers pathophysiology and emerging treatment options as well as innovations to keep patients and healthcare professionals safe.

This week, we’re bringing you part 1 of our series on critical care during the COVID-19 era, starting with early experiences and lessons from critical care physicians in the COVID-19 pandemic. Together they sort through some of the early information and misinformation in the early months of the pandemic. This conversation was recorded on March 31, 2020.

On this week’s show, we’re looking at a different aspect of how healthcare professionals are impacted by the COVID-19 crisis. The pandemic has turned everyone’s lives, professional and personal, upside down, and we wanted to know, how does this new normal affect surgeons’ careers, family, and even pregnancies? Working with the International Society of Endovascular Specialists, we brought together a panel of physicians from around the United States to discuss.

Patients with congenital heart disease are living longer than ever, making adult congenital heart disease (ACHD) a growing specialty. ACHD experts Dr. Ari Cedars and Dr. Hani Najm join Houston Methodist physicians to discuss opportunities and challenges for physicians in the ACHD space.

A timely discussion on ECMO during the coronavirus pandemic.

In the premiere of CV Now, we’re discussing technological innovations and collaborations that have the potential to revolutionize cardiovascular medicine. Listen to interviews with Drs. Sanjiv Narayan and Elliot Chaikof, experts in translational medicine, as they discuss new mapping techniques for atrial fibrillation and training a new generation of surgeon-innovators.